Malaria vaccines

Malaria: Molecular and Clinical Aspects

Volumn , Issue , 1999, Pages 439-493

  Rogers, William O ^a   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057709387     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (438)

1. Abdalla, S., Weatherall, D.J., Wickramasinghe, S.N. and Hughes, M. (1980). The anaemia of P. falciparum malaria. Br. J. Haematol., 46, 171–183.
2. Adams, J.H., Sim, B.K.L., Dolan, S.A., Fang, X., Kaslow, D. and Miller, L. (1992). A family of erythrocyte binding proteins of malaria parasites. PNAS, 89, 7085–7089.
3. Aggarwal, A., Kumar, S., Jaffe, R., Hone, D., Gross, M., and Sadoff, J. (1991). Oral Salmonella: malaria eircumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J. Exp. Med., 172, 1083–1090.
4. Aguiar, J.C., Albrecht, G.R., Cegielski, P., Greenwood, B.M., Jensen, J.B., Lallinger, G. et al. (1992). Agglutination of Plasmodium falciparum-infected erythrocytes from East and West African isolates by human sera from distant geographic regions. Am. J. Trop. Med. Hyg., 47, 621–632.
5. Aikawa, M., Adkinson, C.T., Beaudoin, L.M., Sedegah, M., Charoenvit, Y and Beaudoin, R. (1990a). Localization of CS and non-CS antigens in the sporogonic stages of Plasmodium yoelii. Bull. World Health Organ., 68 (Suppl.), 165–171.
6. Aikawa, M., Torii, M., Sjolander, A., Berzins, K., Perlmann, P. and Miller, L.H. (1990b). Pf 155/RES A antigen is localized in dense granules of Plasmodium falciparum merozoites. Exp. Parasitol., 71, 326–329.
7. al-Yaman, E, Genton, B., Anders, R., Falk, M., Triglia, T., Lewis, D. et al. (1994). Relationship between humoral response to Plasmodiumfalciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am. J. Trop. Med. Hyg., 51, 593–602.
8. al-Yaman, E, Genton, B., Kramer, K.J., Chang, S.P., Hui, G.S., Baisor, M. et al. (1996). Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. Am. J. Trop. Med. Hyg., 54, 443–448.
9. al-Yaman, F., Genton, B., Reeder, J.C., Mokela, D., Anders, R. and Alpers, M. (1997). Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype. Am. J. Trop. Med. Hyg., 56, 430–435.
10. al Yarnan, F., Genton, B., Anders, R., Taraika, J., Ginny, M., Mellor, S. et al. (1995). Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Para site Immunol., 17, 493–501.
11. Allen, S., van der Perre, P., Serufilira, A., Lepage, P., Carael, M., DeClercq, A. et al. (1991). Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J. Infect. Dis., 164, 67–71.
12. Alonso, P.L., Lindsay, S.W., Armstrong Schellenberg, J.R.M., Keita, K., Gomez, P., Shenton, F.C. et al. (1993). A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, West Africa. Trans. Roy. Soc. Trop. Med. Hyg., 87(supplement 2), 37–44.
13. Aribot, G., Rogier, C., Sarthou, J.L., Trape, J.F., Balde, A.T., Druilhe, P. et al.(1996). Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). Am. J. Trop. Med. Hyg., 54, 449–457.
14. Astagneau, P., Chougnet, C, Lepers, J.P, Andriamangatiana Rason, M.D. and Deloron, P. (1994). Antibodies to the 4-mer repeat of the ring-infected erythrocyte surface antigen (Pf 155/RES A) protect against Plasmodium falciparum malaria. Int. J. Epidemiol., 23, 169–175.
15. Baker, D.A., Daramola, O., McCrossan, M.V., Harmer, J. and Targett, G.A.T. (1994). Subcellular localization of Pfsl6, a Plasm odium falciparum gametocyte anti gen. Parasitology, 108, 129–137.
16. Ballou, W.R., Hoffman, S.L., Sherwood, J.A., Hollingdale, M.R., Neva, FA., Hockmeyer, W.T. et al. (1987). Safety and efficacy of a recombinant DNA Plasmodiumfalciparum sporozoite vaccine. Lancet, 1277–1281.
17. Banyal, H.S. and Inselburg, J. (1985). Isolation and characterization of parasite-inhibitory Plasmodiumfalciparum monoclonal antibodies. Am. J. Trop. Med. Hyg., 34, 1055–1064.
18. Barr, P.J., Inselburg, J., Green, K.M., Chang, S.P., Nui, G.S.N., Siddiqui, W.A. et al. (1997). Immunogenicity of recombinant Plasmodium falciparum SERA proteins in rodents. Mol. Biochem. Parasitol., 45, 159–179.
19. Baruch, D.L, Pasloske, B.L., Singh, H.B., Bi, X., Ma, X.c., Feldman, M. et al. (1995). Cloning the P. falciparum gene encoding PffiMPI, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell, 82, 77–87.
20. Bate, C.A.W. and Kwiatowski, D. (1994). Inhibitory immunoglobulin M antibodies to tumour necrosis factor-inducing toxins in patients with malaria. Infect. Immun., 62, 3086–3091.
21. Bate, C.A.W., Taverne, J., Bootsma, H.J., Mason, R.C.S., Skalko, N., Gregoriadis, G. et al. (1992a). Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology, 76, 35–41.
22. Bate, C.A.W., Taverne, J., Roman, E., Moreno, C. and Playfair, J.H. L. (1992b). Tumour necrosis factor induction by malarial exoantigens depends on phospholipid. Immunology, 75, 129–135.
23. Bate, C.A.W., Taverne, J. and Playfair, J.H.L. (1988). Malarial parasites induce TNF production by macrophages. Immunology, 64, 227–231.
24. Bate, C.A.W., Taverne, J. and Playfair, J.H.L. (1989). Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. lmmunology, 66, 600–605.
25. Beach, R.F., Ruebush, T.K., Sexton, J.D., Bright, P.L., Hightower, A.W., Breman, J.G. et al. (1993). Effectiveness of permethrin-impregnated bed nets and curtains for malaria control in holoendemic area of western Kenya. Am. J. Trop. Med. Hyg., 49, 290–300.
26. Beck, H.P., Felger, J., Genton, B., Alexander, N., al-Yaman, F., Anders, R.F. et al. (1995). Humoral and cell mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria. Infect. Immun., 63, 596–600.
27. Behr, C. and Dubois, P. (1992). Preferential expansion of V gamma 9 V delta 2 T cells following stimulation of peripheral blood lymphocytes with extracts of Plasmodium falciparum. Int. Immunol., 4, 361–366.
28. Benmohamed, L., Gras-Masse, H., Tartar, A., Daubersies, P., Brahimi, K., Bossus, M. et al. (1997). Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur. J. Immunol., 27, 1242–1253.
29. Berzins, K.(1991). Pfl55/RESA is not a surface antigen of Plasmodium falciparum-infected eruthrocytes. Parasitol. Today, 7, 193–194.
30. Berzins, K., Adams, S., Broderson, J.R., Chizzolini, C., Hansson, M., Lovgren, K. et al.(1995). Immunogenicity in Aotus monkeys of ISCOM formulated repeat sequences from the Plasmodiumfalciparum asexual blood stage antigen Pfl55/RESA. Vaccine Res., 4, 121–133.
31. Berzins, K., Perlmann, H., Wahlin, B., Carlsson, J., Wahlgren, M., Udomsangpetch, I. et al. (1986). Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pfl55, react with the native protein and inhibit merozoite invasion. PNAS, 83, 1065–1069.
32. Berzins, K, Perl mann, H., Wahlin, B., Ekre, H.P., Hogh, B., Petersen, E. et al. (1991). Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pfl55JRESA. Infect. Immun., 59, 1500–1506.
33. Bianco, A., Battye, F. and Brown, G. (1986). Plasmodium falciparum: rapid quantification of parasitemia in fixed malaria cultures by flow cytometry. Exp. Parasitol., 62, 275–282.
34. Biggs, B.A, Gooze, L., Wycherley, K., Wollish, W., Southwell, B., Leech, J.H. et al. (1991). Antigenic variation in Plasmodium falciparum. PNAS, 88, 9171–9174.
35. Billewicz, W.Z. and McGregor, LA. (1981). The demography of two West African (Gambian) villages 1951–1975. J. Biosoc. Sci., 13, 219–240.
36. Blackman, M.J., Dennis, E.D., Hirst, E.M.A., Kocken, C.H., Scott-Finnigan, T.J. and Thomas, A.W. (1996). Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1. Exp. Parasitol., 83, 229–239.
37. Blackman, M.J., Heidrich, H.G., Donaehie, S., McBride, J.S. and Holder, A.A. (1990). A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med., 172, 379–382.
38. Blackman, M.J. and Holder, A.A. (1992). Secondary processing ofthe Plasmodiumfalciparum merozoite surface protein-1 (MSPl) by a calcium-dependent, membrane-bound serine protease: Shedding of MSPI33 as a noncovalently associated complex with other fragments of the MSPJ. Mol. Biochem. Parasitol., 50, 307–316.
39. Blackman, M.J., Ling, I.T., Nicholls, S.C. and Holder, A.A. (1991). Proteolytic processing of the Plasmodium falciparum merozoite surface protein-l produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol., 49, 29–34.
40. Blackman, M.J., Scott Finnigan, T.J., Shai, S. and Holder, A.A. (1994). Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med., 180, 389–393.
41. Blackman, M.J., Whittle, H. and Holder, A.A. (1991). Processing of the Plasmodium falciparum merozoite surface protein-1: Identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. Mol. Biochem. Parasitol., 49, 35–44.
42. Borst, P., Rudenko, G., Taylor, M.C., Blundell, P.A., Van Leeuwen, F., Bitter, W. et al. (1996). Antigenic variation in trypanosomes. Arch. Med. Res., 27, 379–388.
43. Bottius, E., Benmohamed, L., Brahimi, K., Gras, H., Lepers, J.P., Raharimalala, L. et al. (1996). A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes. J. Immunol., 156, 2874–2884.
44. Bouharoun Tayoun, H., Attanath, P., Sabchareon, A., Chongsuphajaisiddhi, T. and Druilhe, P. (1990). Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med., 172, 1633–1641.
45. Bouharoun Tayoun, H. and Druilhe, P. (1992). Plasmodium falciparum malaria: evidence for an isotype imbalance which may be reponsible for delayed acquisition of protective immunity. Infect. Immun., 60, 1473–1481.
46. Bouharoun Tayoun, H., Oeuvray, C., Lunel, F. and Druilhe, P. (1995). Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med., 182, 409–418.
47. Boyd, M.F. and Matthews, C.B. (1939). Further observations on the duration of immunity to the homologous strain of Plasmodium vivax. Am. J. Trop. Med., 19, 63–67.
48. Brake, D.A., Weidanz, WP. and Long, C.A. (1986). Antigen-specific, interleukin 2-propagated T lymphocytes confer resistance to a murine malarial parasite, Plasmodium chabaudi adami. J. Immunol., 137, 347–352.
49. Bruce, M.R., Carter, R.N., Nakamura, K., Aikawa, M. and Carter, R. (1994). Cellular location and temporal expression of the Plasmodium falciparum sexual stage antigen Pfs16. Mol. Biochem. Parasitol., 65, 1122.
50. Burghaus, P.A. and Holder, A.A. (1994). Expresson of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol. Biochem. Parasitol., 64, 165–169.
51. Burghaus, P.A., Wellde, B.T., Hall, T., Richards, R.L., Egan, A.F., Riley, E.M. et al. (1996). Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection. Infect. Immun., 64, 3614–3619.
52. Butcher, G.A. (1992). HIV and malaria: a lesson in immunology? Parasitol. Today, 8, 307–311.
53. Butcher, G.A. and Clark, I.A. (1990). The inhibition of Plasmodium falciparum growth in vitro by SERA from mice infected with malaria or treated with TNF. Parasitology, 101 Pt3, 321–326.
54. Bzik, D.J., Li, W.B., Horii, T. and Inselburg, J. (1988). Amino acid sequence of the serine-repeat antigen (SERA) of Plasmodium falciparum determined from cloned cDNA. Mol. Biochem. Parasitol., 30, 279–288.
55. Carlson, J., Holmquist, G., Taylor, D.W., Perlmann, P. and Wahlgren, M. (1990). Antibodies to a histidine rich protein (PfflRPI) disrupt spontaneously formed Plasmodium falciparum erythrocyte rosettes. PNAS, 87, 2511–2515.
56. Carter, R., Graves, P.M., Quakyi, I.A. and Good, M.F. (1989). Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies. J. Exp. Med., 169, 135–147.
57. Cavacini, L.A., Long, C.A. and Weidanz, W.P. (1986). T-cell immunity in murine malaria: adoptive transfer of resistance to Plasmodium chabaudi adami in nude mice with splenic T cells. Infect. Immun., 52, 637–643.
58. Cavacini, L.A., Parke, L.A. and Weidanz, WP. (1990). Resolution of acute malaria infections by T cell-dependent non-antibody-mediated mechanisms of immunity. Infect. Immun., 58, 2946–2950.
59. Cerami, C., Frevert, U., Sinnis, P., Takacs, B., Clavijo, P., Santos, M.J. et al. (1992). The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell, 70, 1021–1033.
60. Cerami, C., Kwakye Berko, E and Nussenzweig, V. (1992). Binding of malarial circumsporozoite protein to sulfatides [Gal(3-S04)pl-Cer] and cholesterol-3-sulfate and its dependence on disulfide bond fonnation between cysteines in region II. Mol. Biochem. Parasitol., 54, 1–12.
61. Chang, S.P., Case, S.E., Gosnell, W.L., Hashimoto, A, Kramer, K.J., Tam, L.Q. et al. (1996). A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun., 64, 253–261.
62. Chappel, J.A. and Holder, A.A. (1993). Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. Mol. Biochem. Parasitol., 60, 303–311.
63. Charoenvit, Y., Collins, W.E., Jones, T.R., Millet, P., Yuan, L., Campbell, G.H. et al. (1991). Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science. 251, 668–671.
64. Charoenvit, Y., Fallarme, V., Rogers, W.O., Sacci, J.B., Jr., Kaur, M., Aguiar, J.C. et al. (1997). Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B cell epitopes. Infect. Immun., 65, 3430–3437.
65. Charoenvit, Y., Leef, M.L., Yuan, L.F., Sedegah, M., and Beaudoin, R.L. (1987). Characterization of Plasmodium yoelii mono clonal antibodies directed against stage-specific sporozoite antigens. Infect. Immun., 55, 604–608.
66. Charoenvit, Y, Mellouk, S., Cole, C., Bechara, R., Leef, M.F, Sedegah, M. et al. (1991). Monoclonal, but not polyclonal antibodies protect against Plasmodium yoelii sporozoites. J. Immunol., 146, 1020–1025.
67. Charoenvit, Y., Mellouk, S., Sedegah, M., Toyoshima, T., Leef, M.E, De la Vega, P. et al. (1995). Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody. Exp. Parasitol., 80, 419–429.
68. Chen, D.H., Tigelaar, R.E. and Weinbaum, F.I. (1977). Immunity to sporozoite-indueed malaria infection in mice. I. The effect of immunization of T and B cell-deficient mice. J. Immunol., 118, 1322–1327.
69. Cheng, Q., Lawrence, G., Reed, C., Stowers, A., Ranford-Cartwright, L., Creasey, A. et al. (1997). Measurement of Plasmodiumfalciparum growth rates in vivo: a test of malaria vaccines. Am. J. Trop. Med. Hyg., 57, 495–500.
70. Cheng, Q. and Saul, A. (1994). Sequence analysis of the apical membrane antigen I (AMA-l) of Plasmodium vivax. Mol. Biochem. Parasitol., 65, 183–187.
71. Cheung, A., Leban, J., Shaw, A.R., Merkli, B., Stocker, J., Chizzolini, C. et al. (1986). Immunization with synthetic peptides of a Plasm odium falciparum surface antigen induces anti-merozoite antibodies. PNAS, 83, 8328–8332.
72. Chitnis, C.E. and Miller, L.H. (1994). Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med., 180, 497–506.
73. Chougnet, C., Tallet, S., Ringwald, P. and Deloron, P. (1992). Kinetics of lymphocyte subsets from peripheral blood during a Plasmodium falciparum malaria attack. Clin. Exp. Immunol., 90, 405–408.
74. Chougnet, C., Troye-Blomberg, M., Deloron, P., Kabilan, L., Lepers, J.P, Savel, J. et al. (1991). Human immune response in Plasmodium falcip arum malaria. Synthetic peptides corresponding to known epitopes of the Pfl55/RESA antigen induce production of parasite specific antibodies in vitro. J. Immunol., 147, 2295–2301.
75. Christophers, S.R. (1924). The mechanism of immunity against malaria in communities living under hyperendemic conditions. Indian J. Med. Res., 12, 273–294.
76. Chulay, J.D., Haynes, J.D. and Diggs, C.L. (1981). Inhibition of in vitro growth of Plasmodium falciparum by immune serum from monkeys. J. Infect. Dis., 144, 270–278.
77. Chulay, J.D., Lyon, J.A, Haynes, J.D., Meierovics, A.I., Atkinson, C.T. and Aikawa, M. (1987), Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum. J. Immunol., 139, 2768–2774.
78. Ciuca, M., Ballif, L. and Chelarescu-Vieru, M. (1934). Immunity in mal aria. Trans. Roy. Soc. Trop. Med. Hyg., 27, 619–622.
79. Clark, LA and Chaudhri, G. (1988). Tumor necrosis factor may contribute to the anaemeia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br. J. Haematol., 70, 99–103.
80. Clark, LA, Rochett, K.A. and Cowden, W.B. (1991). Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol. Today, 7, 205–207.
81. Clark, J.T., Donachie, S., Anand, R., Wilson, C.F., Heidrich, H.-G. and McBride, J.S. (1988). 46–53 kD glycoprotein from the surface of Plasmodium falciparum merozoites. Mol. Biochem. Parasitol., 32, 15–24.
82. Clyde, D.F., McCarthy, V.C., Miller, R.M. and Hornick, R.B. (1973a). Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci., 266, 398–401.
83. Clyde, D.F, McCarthy, VC., Miller, R.M. and Woodward, W.E. (1975). Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg., 24, 397–401.
84. Clyde, D.F, Most, H., McCarthy, V.C. and Vanderberg, J.P. (1973b). Immunization of man against sporozoite-induced falciparum malaria. Am. J. Med. Sci., 266, 169–177.
85. Cochrane, AH., Masamichi, A, Jeng, M. and Nussenzweig, R.S. (1976). Antibody-induced ultrastruetural changes of malarial sporozoites. J. Immunol., 116, 859–867.
86. Cohen, S., McGregor, LA and Carrington, S. (1961). Gamma-globulin and acquired immunity to human malaria. Nature, 192, 733–737.
87. Colebunders, R., Bahwe, Y, Nekwei, W., Ryder, R., Perriens, J., Nsimba, K. et al. (1990). Incidence of malaria and efficacy of oral quinine in patients recently infected with human immuodeficiency virus in Kinshasha, Zaire. J. Infect., 21, 167–173.
88. Collins, W.E., Anders, R.F, Pappaioanou, M., Campbell, G.H., Brown, G.V., Kemp, D.J. et al. (1986). Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature, 323, 259–262.
89. Collins, W.E., Anders, R.F., Ruebush, T.K., Kemp, D.J., Woodrow, G.C., Campbell, G.H. et al. (1991). Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodiumfalciparum. Am. J. Trop. Med. Hyg., 44, 34–41.
90. Collins, W.E., Nussenzweig, R.S., Ballou, W.R., Ruebush, T.K., Nardin, E.H., Chulay, ID. et al. (1989). Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the cireumsporozoite protein of Plasmodium vivax. Am. J. Trop. Med. Hyg., 40, 455–464.
91. Collins, W.E., Pye, D., Crewther, P.E., Vandenberg, K.L., Galland, G.G., Sulzer, A.J. et al. (1994). Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-l of Plasmodium fragile. Am. J. Trop. Med. Hyg., 51, 711–719.
92. Collins, W.E., Sullivan, J.S., Morris, C.L., Galland, G.G., Jue, D.L., Fang, S. et al. (1997). Protective immunity induced in squirrel monkeys with a multiple antigen construct against the circumsporozoite protein of Plasmodium vivax. Am. J. Trop. Med. Hyg., 56, 200–210.
93. Conway, D.J., Greenwood, B.M. and McBride, J.S. (1992). Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population. Infect. Immun., 60, 1122–1127.
94. Covell, G. and Nicol, W.D. (1951). Clinical, chemotherapeutic and immuological studies on induced malaria. Br. Med. Bull., 8, 51–55.
95. Creasey, A., Fenton, G., Walker, A, Thaithong, S., Oliveira, S., Mutambu, S. et al. (1990). Genetic diversity of Plasmodium falciparum shows geographic variation. Am. J. Trop. Med. Hyg., 42, 403–413.
96. Crewther, P.E., Culvenor, J.G., Silva, A., Cooper, J.A. and Anders, R.E. (1990). Plasmodium falciparum — 2 antigens of similar size are located in different compartments of the rhoptry. Exp. Parasitol., 70, 193–206.
97. Culvenor, J.G., Day, K.P. and Anders, R.F. (1991). Plasmodium falciparum ring infected erythrocyte surface antigen is released from merozoite dense granules after invasion. Infect. Immun., 59, 1183–1187.
98. Currier, J., Beck, H.-P., Currie, B. and Good, M.F. (1995). Antigens released at schizont burst stimulate Plasmodium falciparum-specific CD4+ T cells from non-exposed donors: potential for cross-reactive memory T cells to cause disease. Int. Immunol., 7, 821–833.
99. Dalton, J.P, McNally, J. and O’Donovan, S.M. (1993). In vitro assays for the study of erythrocyte invasion by malarial parasites. Parasitol. Today, 9, 109–111.
100. Daly, T.M. and Long, CA. (1995). Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol., 155, 236–243.
101. David, P.H., Hommel, M., Miller, L.H., Udeinya, I.J. and Oligino, L.D. (1983). Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. PNAS, 80, 5075–5079.
102. De Zoysa, A.P., Herath, P.R., Abhayawardana, T.A, Padmalal, U.K. and Mendis, K.N. (1988). Modulation of human malaria transmission by anti-gamete transmission blocking immunity. Tram. Roy. Soc. Trop. Med. Hyg., 82, 548–553.
103. De Zoysa, A.P., Mendis, C., Gamage Mendis, A.C., Weerasinghe, S., Herath, P.R. and Mendis, K.N. (1991). A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission-blocking immunity in an endemic area. Bull. World Health Organ., 69, 725–734.
104. Deans, J.A., Alderson, T., Thomas, A.W., Mitchell, G.H., Lennox, E.S. and Cohen, S. (1982). Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin. Exp. Immunol., 49, 297–309.
105. Debrabant, A., Maes, P., Delplace, P., Dubremetz, J.F., Tartar, A and Camus, D. (1992). Intramolecular mapping of Plasmodiumfalciparum pl26 proteolytic fragments by N-terminal amino acid sequencing. Mol. Biochem. Parasitol., 53. 89–95.
106. del Portillo, H.A, Longacre, S., Khouri, E. and David, P.H. (1991). Primary structure of the merozoite surface antigen-1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. PNAS, 88, 4030–4034.
107. del Portillo, H.A, Nussenzweig, R.S. and Enea, V. (1987). Circumsporozoite gene of a Plasmodiumfalciparum strain from Thailand. Mol. Biochem. Parasitol., 24, 289–294.
108. Deleersnijder, W., Hendrix, D., Bendahman, N., Hanegreefs, J., Brijs, L., Hamerscastennan, C. et al.(1990). Molecular cloning and sequence analysis of the major merozoite surface antigen of Plasmodium chabaudi. Mol. Biochem. Parasitol., 43, 231—244.
109. Delplace, P., Bhatia, A., Cagnard, M., Camus, D., Colombet, G., Debrabant, A. et al. (1988). Protein pl26: a parasitophorous vacuole antigen associated with the release of Plasmodiumfalciparum merozoites. Biol. Cell, 64, 215–221.
110. Delplace, P., Fortier, B., Tronchin, G., Dubremetz, J.F. and Vernes, A. (1987). Localization, biosynthesis, processing and isolation of a major 126 kDa antigen of the parasitophorous vacuole of Plasmodium falciparum. Mol. Biochem. Parasitol., 23, 193–201.
111. Desowitz, R.S. (1991). The Malaria Capers. New York: W.W. Norton and Company.
112. Diggs, C.L., Ballou, W.R. and Miller, L.H.(1993). The major merozoite surface protein as a malaria vaccine target. Parasitol. Today, 9. 300–302.
113. Donnelly, J.J., Ulmer, J.B., Shiver, J.W. and Liu, M.A. (1997). DNA vaccines. Annu. Rev. Immunol., 15, 617–648.
114. Doolan, D.L., Hedstrom, R.C., Rogers, W.O., Charoenvit, Y, Rogers, M., De la Vega, P. et al. (1996). Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoeHi, homolog of Plasmodium falciparum exported protein 1. J. Biol. Chem., 271, 17861–17868.
115. Doolan, D.L. and Hoffman, S.L. (1997). Multi-gene vaccination against malaria: a multistage, multi-immune response approach. Parasitol. Today, 13, 171–178.
116. Doolan, D.L., Hoffman, S.L., Southwood, S., Wentworth, P.A., Sidney, J., Chesnut, R.W. et al. (1997). Degenerate cytotoxic T cell epitopes from P falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity, 7, 97–112.
117. Doolan, D.L., Saul, A.J. and Good, M.F. (1992). Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development. Infect. Immun., 60, 675–682.
118. Doolan, D.L., Sedegah, M., Hedstrom, R.C., Hobart, P., Charoenvit, Y and Hoffman, S.L. (1996). Circumventing genetic restriction of protection against malaria with multi-gene DNA immunization: CD8+ T cell, interferon-gamma, and nitric oxide dependent immunity. J. Exp. Med., 183, 1739–1746.
119. Duffy, P.E. and Kaslow, D.C. (1997). A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission blocking vaccines. Infect. Immun., 65, 1109–1113.
120. Dye, C. and Targett, G.(1994). A theory of malaria vaeeination. Nature, 370, 95–96.
121. Edozien, J.C., Gilles, H.M. and Udeozo, I.O.K. (1962). Adult and cord-blood gamma-globulin and immunity to malaria in Nigerians. Lancet, 2, 951–955.
122. Egan, A., Waterfall, M., Pinder, M., Holder, A., and Riley, E. (1997). Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: Evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds. Infect. Immun., 65, 3024–3031.
123. Egan, A.F., Chappel, J.A., Burghaus, P.A, Morris, J.S., McBride, J.S., Holder, A.A. et al. (1995). Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSPI19, the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect. Immun., 63, 456–466.
124. Egan, AF., Monis, J., Bamish, G., Allen, S., Greenwood, B.M., Kaslow, D.C. et al. (1996). Clinical immunity to Plasmodium falciparum malaria is asociated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-l. J. Infect. Dis., 173, 765–769.
125. Egan, J.E., Hoffman, S.L., Haynes, J.D., Sadoff, J.C., Schneider, I., Grau, G.E. et al. (1993). Humoral immune response in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg., 49, 166–173.
126. Egan, J.E., Weber, J.L., Ballou, W.R., Hollingdale, M.R., Majarian, W.R., Gordon, D.M. et al. (1987). Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science, 236, 453–456.
127. Elased, K., De Souza, J.B. and Playfair, J.H. (1995). Blood-stage malaria infection in diabetic mice. Clin. Exp. Immunol., 99, 440–444.
128. Elased, K. and Playfair, J.H. (1994). Hypoglycemia and hyperinsulinemia in rodent models of severe malaria infection. Infect. Immun., 62, 5157–5160.
129. Elloso, M.M., van der Heyde, H.C., Troutt, A., Manning, D.D. and Weidanz, W.P. (1996). Human gamma delta T cell subset-proliferative response to malarial antigen in vitro depends on CD4+ T cells or cytokines that signal through components of the IL-2R. J. Immunol., 157, 2096–2102.
130. Elloso, M.M., van der Heyde, H.C., Vande Waa, J.A., Manning, D.D. and Weidanz, WP. (1994). Inhibition of Plasmodium falciparum in vitro by human gamma delta T cells. J. Immunol., 153, 1187–1194.
131. Epping, R.J., Goldstone, S.D., Ingram, L.T., Upcroft, J.A., Ramasamy, R., Cooper, J. A. et al. (1988). An epitope recognized by inhibitory monoclonal antibodies that react with a 51 kilodalton merozoite surface antigen in Plasmodium falciparum. Mol. Biochem. Parasitol., 28, 1–10.
132. Esslinger, C.W., Picot, S. and Ambroise Thomas, P. (1994). Intra-erythrocytic Plasmodium falciparum induces up-regulation of inter-cellular adhesion molecule-1 on human endothelial cells in vitro. Scand. J. Immunol., 39, 229–232.
133. Etlinger, H.M., Caspers, P., Matile, H., Schoenfeld, H.J., Stueber, D. and Takacs, B. (1991). Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparium. Infect. Immun., 59, 3498–3503.
134. Fenton, B., Clark, J.T, Khan, C.M.A., Robinson, J.V., Walliker, D., Ridley, R. et al. (1991). Structural and antigenic polymorphism of the 35- to 48-kDa merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol. Cell. Biol., 11, 963–971.
135. Ferreira, A., Schofield, L., Enea, V., Schellekens, J-J., van der Meide, P., Collins, W.E. et al. (1986). Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science, 232, 881–884.
136. Fidock, D.A., Bottius, E., Brahimi, K., Moelans, J.J., Aikawa, M., Konings, R.N. et al. (1994a). Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP. Mol. Biochem. Parasitol., 64, 219–232.
137. Fidock, D.A., Gras Masse, H., Lepers, J.P., Brahimi, K., Benmohamed, L., Mellouk, S. et al. (1994b). Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J. Immunol., 153, 190–204.
138. Fidock, D.A., Sallenave Sales, S., Sherwood, J.A., Gaehihi, G.S., Ferreira da Cruz, M.F., Thomas, A.W. et al. (1994c), Conservation of the Plasmodium falciparum sporozoite surface protein gene, STARP, in field isolates and distinct species of Plasmodium. Mol. Biochem. Parasitol., 67, 255–267.
139. Fine, E., Aikawa, M., Cochrane, A.H. and Nussenzweig, R.S. (1984). Immuno-eleetron microscopic observations on Plasmodium knowlesi sporozoites: localization of protective antigen and its precursors. Am. J. Trop. Med. Hyg., 33, 220–226.
140. Foley, M., Tilley, L., Sawyer, W.H. and Anders, R.F. (1991). The ring-infected erythrocyte surface antigen of Plasmodiumfalciparum associates with spectrin in the erythrocyte membrane. Mol. Biochem. Parasitol., 46, 137–148.
141. Forsyth, K.P., Philip, G., Smith, T, Kum, S., Southwell, B. and Brown, G.V. (1989). Diversity of antigens expressed on the surface of the erythrocytes infected with mature Plasmodium falciparum parasites in Papua New Guinea. Am. J. Trop. Med. Hyg., 41, 259–265.
142. Fox, B.A., Pang, XL., Suzue, K, Horii, T and Bzik, D. (1997). Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies. Exp. Parasitol., 85, 121–134.
143. Fraser, T., Miehon, P, Barnwell, J.W., Noe, A.R., al-Yaman, F., Kaslow, D.C. et al. (1997). Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein. Infect. Immun., 65, 2772–2777.
144. Fries, H.C., Lamers, M.B., van Deursen, J., Ponnudurai, T and Meuwissen, J.H. (1990). Biosynthesis of the 25-kDa protein in the macrogametes/zygotes of Plasmodium falciparum. Exp. Parasitol., 71, 229–235.
145. Fries, L.F., Gordon, D.M., Schneider, J., Beier, J.C., Long, G.W., Gross, M., et al. (1992). Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A. Infect. Immun., 60, 1834–1839.
146. Gamage Mendis, A.C., Rajakaruna, J., Carter, R. and Mendis, KN. (1992). Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka. Parasite Immunol 14, 385–396.
147. Gerold, P., Schofield, L., Blackman, M.J., Holder, A.A. and Schwarz, R.T. (1996). Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite proteins-1 and -2 of Plasmodiumfalciparum. Mol. Biochem. Parasitol., 75, 131–143.
148. Goerlich, R., Hacker, G., Pfeffer, K., Heeg, K. and Wagner, H. (1991). Plasmodium falciparum merozoites primarily stimulate the V gamma 9 subset of human gamma delta T cells. Eur. J. Immunol., 21, 2613–2618.
149. Good, M.F., Maloy, W.L., Lunde, M.N., Margalit, H., Cornette, J.L., Smith, G.L. et al. (1987a). Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. Science, 235, 1059–1062.
150. Good, M.F., Pombo, D., Quakyi, LA., Riley, E.M., Houghten, R.A., Menon, A. et al. (1987b). Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule. PNAS, 85, 1199—1203.
151. Good, M.F., Quakyi, LA., Saul, A., Berzofsky, J.A., Carter, R. and Miller, L.H. (1987c). Human T clones reactive to the sexual stages of Plasmodium falciparum malaria: high frequency of gamete-reactive T cells in peripheral blood from non-exposed donors. J. Immunol., 138, 306–311.
152. Goodier, M., Fey, P., Eichmann, K and Langhorne, J. (1992). Human peripheral blood gamma delta T cells respond to antigens of Plasmodium falciparum. Int. Immunol., 4, 33--41.
153. Goodier, M., Krause-Jauer, M., Sanni, A., Massougbodji, A., Sadeler, B.-C., Mitchell, G.H. et al. (1993). Gamma delta T cells in the peripheral blood of individuals from an area of holoendemic Plasmodium falciparum transmission. Trans. Roy. Soc. Trop. Med. Hyg., 87, 692–696.
154. Gordon, D.M., McGovern, T.W., Krzych, U., Cohen, J.C., Schneider, L, LaChance, Ret al. (1995). Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J. Infect. Dis., 171, 1576—1585.
155. Goundis, D. and Reid, K.B.M. (1988). Properdin, the terminal complement components, thrombospondin, and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature, 335, 82—85.
156. Gowda, D.C., Gupta, P. and Davidson, E.A. (1997). Glycosylphosphatidylinositol anchors represent the major carbohydrate modification in proteins of intraerythrocytic stage. Plasmodium falciparum. J. Biol. Chem., 272, 6428—6439.
157. Gramzinski, R.A., Maris, D.C., Doolan, D., Charoenvit, Y, Obaldia, N., Rossan, R. et al. (1997). Malaria DNA vaccines in Aotus monkeys. Vaccine, 15, 913—915.
158. Gramzinski, R.A., Maris, D.C, Obaldia, N., Rossan, R., Sedegah, M., Wang, R. et al. (1996). Optimization of antibody responses of a malaria DNA vaccine in Aotus monkeys. Vaccine Res., 5, 173–183.
159. Graves, P.M., Carter, R., Burkot, T.R, Quakyi, LA. and Kumar, N. (1988). Antibodies to Plasmodiumfalciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol., 10, 209–218.
160. Graves, P.M., Doubrovsky, A., Sattabongkot, J. and Battistutta, D. (1992). Human antibody responses to epitopes on the P. falciparum gametocyte antigen Pfs48/45 and their relationship to infectivity of gametocyte carers. Am. J. Trop. Med. Hyg., 46, 711–719.
161. Grun, J.L. and Weidanz, W.P. (1981). Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse. Nature, 290, 143–145.
162. Guerin-Marchand, C., Druilhe, P., Galey, B., Londono, A., Patarapotikul, J., Beaudoin, R.L. et al. (1987). A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature, 329, 164–167.
163. Gupta, S. and Day, K.P. (1994). A theoretical framework for the immunoepidemiology of Plasmodiumfalciparum malaria. Parasite Immunol., 16, 361—370.
164. Gupta, S., Hill, A.V., Kwiatkowski, D., Greenwood, A.M., Greenwood, B.M. and Day, K.P. (1994a). Parasite virulence and disease patterns in Plasmodium falciparum malaria. PNAS, 91, 3715—3719.
165. Gupta, S., Trenholme, K., Anderson, R.M. and Day, KP. (1994b). Antigenic diversity and the transmission dynamics of Plasmodium falciparum. Science, 263, 961—963.
166. Gwadz, R.W, Cochrane, A.H., Nussenzweig, V. and Nussenzweig, R.S. (1979). Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull. World Health Organ., 57(Suppl. 1), 165–173.
167. Gwadz, R.W. and Koontz, L.C. (1984). Plasmodium knowlesi: persistence of transmission blocking immunity in monkeys immunized with gamete antigens. Infect. Immun., 44, 137—140.
168. Gyan, B., Troye-Blomberg, M., Perlmann, P. and Bjorkman, A. (1994). Human monocytes cultured with and without interferon-gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediate s. Parasite Immunol., 16, 371–375.
169. Hall, R., Hyde, J.E., Goman, M., Simmons, D.L., Hope, I.A., Mackay, M. et al. (1984). Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature, 311, 379–382.
170. Hamyuttanakorn, P., McBride, J.S., Donachie, S., Heidrich, H.-G. and Ridley, R.G. (1992). Inhibitory monoclonal antibodies recognise epitopes adjacent to a proteolytic cleavage site on the RAP-1 protein of Plasmodium falciparum. Mol. Biochem. Parasitol., 55, 177–186.
171. Healer, J., McGuiness, D., Hopcroft, P., Haley, S., Carter, R and Riley, E. (1997). Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human SERA is associated with antibodies to the gamete surface antigen Pfs230. Infect. Immun., 65, 3017–3023.
172. Hedstrom, R.C., Campbell, J.R., Leef, M.L., Charoenvit, Y, Carter, M., Sedegah, M. et al. (1990). A malaria sporozoite surface antigen distinct from the circumsporozoite protein. Bull. World Health Organ., 68 (Suppl.), 152–157.
173. Helmby, H., Cavelier, L., Pettersson, U. and Wahlgren, M. (1993). Rosetting Plasmodium falciparum-infected erythrocytes express unique strain-specific antigens on their surface. Infect. Immun., 61, 284–288.
174. Herrera, M.A., Rosero, E, Herrera, S., Caspers, P., Rotmann, D., Sinigaglia, F. et al. (1992). Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection. Infect. Immun., 60, 154–158.
175. Herrington, D., Davis, J., Nardin, E., Beier, M., Cortese, J., Eddy, H. et al. (1991). Successful immunization of humans with irradiated sporozoites: humoral and cellular responses of the protected individuals. Am. J. Trop. Meil. Hyg.,45, 539–547.
176. Herrington, D.A., Clyde, D.F, Losonsky, G., Cortesia, M., Murphy, J.R., Davis, J. et al. (1987). Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodiumfalciparum sporozoites. Nature, 328, 257–259.
177. Hill, A.V.S., Allsopp, C.E.M., Kwiatkowki, D., Anstey, N.M., Twumasi, P, Rowe, P.A. et al. (1991). Common West African HLA antigens are associated with protection from severe malaria. Nature, 352, 595–600.
178. Hill, A.V.S., Elvin, J., Willis, A.C., Aidoo, M., Allsopp, C.E., Goteh, FM. et al.(1992). Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature, 360, 434–439.
179. Hill, R.B., Cambournac, F.J.C. and Simoes, M.P. (1943). Observations on the course of malaria in chilren in an endemic region. Am. J. Trop. Med., 23, 147–162.
180. Ho, M., Tongtawe, P., Kriangkum, J., Wimonwattrawatee, T., Pattanapanyasat, K., Bryant, L. et al. (1994). Polyclonal expansion of peripheral gamma delta T cells in human Plasmodium falciparum malaria. Infect. Immun., 62, 855–862.
181. Ho, M., Webster, H.K., Tongtawe, P., Pattanapanyasat, K. and Weidanz, W.P. (1990). Increased gamma delta T cells in acute Plasmodiumfalciparum malaria. Imm unol. Lett., 25, 139–142.
182. Hoffman, S.L., Crutcher, J.M., Puri, S.K., Ansari, A.A., Villinger, F., Franke, E.D. et al. (1997). Sterile protection of monkeys against malaria after administration of interleukin-12. Nat. Med., 3, 80–83.
183. Hoffman, S.L., Edelman, R, Bryan, J., Schneider, J., Davis, J., Sedegah, M. et al. (1994). Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria and squalene as adjuvant. Am. J. Trop. Med. Hyg., 51, 603–612.
184. Hoffman, S.L., Isenbarger, D., Long, G.W., Sedegah, M., Szarfman, A., Waters, L. et al.(1989a). Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science, 244, 1078–1081.
185. Hoffman, S.L., Oster, C.N., Mason, C., Beier, J.C., Sherwood, J.A., Ballou, W.R. et al. (1989b). Human lymphoctye proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J. Imm unol., 142, 1299–1303.
186. Hoffman, S.L., Oster, C.N., Plowe, C.v., Woollett, G.R., Beier, J.C., Chulay, J.D. et al. (1987). Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science, 237, 639–642.
187. Hoffman, S.L., Weiss, W., Mellouk, S. and Sedegah, M. (1990). Irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes. Imm unol. Lett., 25, 33–38.
188. Holder, A.A., Freeman, R.R. and Nicholls, S.C. (1988). Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Parasite Immunol, 10, 607–617.
189. Holder, A.A., Sandhu, J.S., Hillman, Y, Davey, L.S., Nicholls, S.C., Cooper, H. et al. (1987). Processing of the presursor to the major merozoite antigens of Plasm odium falciparum. Parasitology, 94, 199–208.
190. Hollingdale, M.R., Collins, W.E., Campbell, C.C. and Schwartz, A.L. (1985)In vitro culture of two populations (dividing and non-dividing) of exo-erythocytic parasites of Plasmodiun vivax., Am. J. Trop. Med. Hyg., 34, 216–222.
191. Hollingdale, M.R, Leland, P., Leef, J.L and Schwartz, A.L. (1983). Entry of Plasmodium berghei sporozoites into cultured cells, and their transformation into trophozoites. Am. J. Trop. Med. Hyg., 32, 685–690.
192. Hollingdale, M.R., Nardin, E.H., Tharavanij, S., Schwartz, A.L. and Nussenzweig, R.S. (1984). Inhibition of entry of Plasmodiumfalciparum an d P vivax sporozoites into cultured cells: an in vitro ass ay of protective antibodies. J. Immunol., 132, 909–913.
193. Horii, T, Bzik, D.J. and Inselburg, J. (1988). Characterization of antigen expressing Plasmodium falciparum cDNA clones that are reactive with parasite inhibitory antibodies. Mol. Biochem. Parasitol., 30, 9–18.
194. Howard, R.(1992). The sequence of the p82 rhoptry protein is highly conserved between two Plasmodium falciparum isolates. Mol. Biochem. Parasitol., 51, 327—330.
195. Howard, R.F. and Peterson, C. (1996). Limited RAP-l sequence diversity in field isolates of Plasmodium falciparum. Mol. Biochem. Parasitol., 77, 95–98.
196. Huber, W., Felger, I., Matile, H., Lipps, H.J., Steiger, S. and Beck, H.-P. (1997). Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3. Mol. Biochem. Parasitol., 87, 231–234.
197. Hviid, L., Kurtzhals, J.A.L, Dodoo, D., Rodrigues, O., Ronn, A., Oliver Commey, J.O. et al. (1996). The gamma! delta T-cell response to Plasmodium falciparum malaria in a population in which malaria is endemic. Infect. Immun., 64, 4359–4362.
198. Hviid, L., Theander, T.G., Abdulhadi, N.H., Abu-Zeid, Y.A., Bayoumi, R.A. and Jensen, J.B. (1991a). Transient depletion of T cells with high LFA-1 expression from peripheral circulation during acute Plasmodium falciparum malaria. Eur. J. Immunol., 21, 1249–1253.
199. Hviid, L., Theander, TG., Abu-Zeid, Y.A., Abdulhadi, N.H., Jakobsen, P.H., Saeed, B.O. et al. (199lb). Loss of cellular immune reactivity during acute Plasmodium falciparum malaria. FEMS Microbiol. Immunol., 3, 219–227.
200. Hviid, L., Theander, T.G., Elhassan, L.M. and Jensen, J.B. (1993). Increased plasma levels of soluble ICAM-1 and ELAM-1 (E-selectin) during acute Plasmodium falciparum malaria. Immunol. Lett., 36, 51–58.
201. Inselburg, J., Bathurst, I.C., Kansopon, J., Barehfeld, G.L., Barr, P.J. and Rossan, R.N. (1993a). Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodiumfalciparum: adjuvant effects on induction of protective imm unity. Infect. Immun., 61, 2041–2047.
202. Inselburg, J., Bathurst, I.C., Kansopon, J., Barr, P.J. and Rossan, R. (1993b). Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant. Infect. Immun., 61, 2048–2052.
203. Inselburg, J., Bzik, D.J., Li, W.B., Green, K.M., Kansopon, J., Hahm, B.K. et al. (1991). Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum. Infect. Immun., 59, 1247–1250.
204. Jacobberger, J., Horan, P. and Hare, J. (1983). Analysis of malaria parasite-infected blood by flow cytometry. Cytometry, 4, 228–232.
205. Jakobsen, PH., Morris-Jones, S., Ronn, A., Hviid, L., Theander, TG., Elhassan, L.M. et al. (1994). Increased plasma concentrations of sICAM-l, sVCAM-l, and sELAM-l in patients with Plasmodium falciparum or P vivax malaria and association with disease severity. Immunology, 83, 665–669.
206. Jayawardena, A.N., Murphy, D.B., Janeway, C.A. and Gershon, R.K.(1982). T cell-mediated immunity in malaria. L The Ly phenotype of T cells mediating resistance to Plasm odium yoelii. J. Immunol., 129, 377–381.
207. Jeffery, G. (1966). Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull. World Health Organ., 35, 873–882.
208. Jongwutiwes, S., Tanabe, K., Hughes, M.K., Kanbara, H. and Hughes, A.L. (1994). Allelic variation in the circumsporozoite protein of Plasmodium falciparum from Thai field isolates. Am. J. Trop. Med. Hyg., 51, 659–668.
209. Kabilan, L., Troye-Blomberg, M., Patarroyo, M.E., Bjorkman, and Perlmann, P. (1987). Regulation of the immune response in Plasmodium falciparum malaria: IV T cell dependent production of immunoglobulin and anti-P falciparum antibodies in vitro. Clin. Exp. Immunol., 68, 288–297.
210. Karunaweera, N.D., Grau, G.E., Gamage, P, Carter, R. and Mendis, K.N. (1992). Dynamics of fever and serum TNF levels are closely associated during clinical paroxysms in P vivax malaria. PNAS, 89, 3200–3203.
211. Kaslow, D.C. (1996). Transmission-blocking vaccines. In: Hoffman, S.L., (Ed.). Malaria Vaccine Development: A Multi-Immune Response Approach, pp. 181–227. Washington, D.C.: American Society for Microbiology.
212. Kaslow, D.C., Quakyi, I.A., Syin, C., Raum, M.G, Keister, D.B., Coligan, J.E. et al (1988). A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature, 333, 74–76.
213. Khan, Z.M. and Vanderberg, J.P. (1992). Specific inflammatory cell infiltration of hepatic schizonts in BALB/c mice immunized with attenuated Plasmodium yoelii sporozoites. Int. Immunol., 4, 711–718.
214. Khusmith, S., Charoenvit, Y., Kumar, S., Sedegah, M., Beaudoin, R.L. and Hoffman, S.L. (1991). Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science, 252, 715–718.
215. Khusmith, S., Sedegah, M. and Hoffman, S.L. (1994). Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T cell clone recognizing sporozoite surface protein 2. Infect. Immun., 62, 2979–2983.
216. Klotz, F.W., Scheller, L.F., Seguin, M.C., Kumar, N., Marietta, M.A., Green, SJ. et al. (1995). Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites. J. Immunol., 154, 3391–3395.
217. Knapp, B., Hundt, E., Nau, U. and Kupper, H.A. (1989). Molecular cloning, genomic structure and localization in a blood stage antigen of Plasmodium falciparum characterized by a serine stretch. Mol. Biochem. Parasitol., 32, 73–84.
218. Kocken, C.H., Jansen, J., Kaan, AM., Beckers, P.J., Ponnudurai, T., Kaslow, D.C. et al. (1993). Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol. Biochem. Parasitol., 61, 59–8.
219. Kumar, S., Yadava, A, Keister, D.B., Tian, J.H., Ohl, M., Perdue Greenfield, K.A. et al. (1995). Immunogenicity and in vivo efficacy of recombinant Plasmodiumfalciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med., 1, 325–332.
220. Kwiatkowski, D., Molyneux, M.E., Stephens, S., Curtis, N., Klein, N., Pointaire, P. et al. (1993). Anti-TNF therapy inhibits fever in cerebral malaria. Q. J. Med., 86, 91–98.
221. Lal, AA., De La Cruz, V.F., Good, M.F., Maloy, W.L., Welsh, J.A, Lunde, M. et al. (1988). Antibodies against the repeat region of circumsporozoite protein are not protective against challenge by sporozoite: a rodent model study. Vaccines, 67–70.
222. Lal, AA., De La Cruz, V.F., Good, M.F., Weiss, W.R., Lunde, M., Maloy, W.L. et al. (1987). In vivo testing of subunit vaccines against malaria sporozoites using a rodent system. PNAS, 84, 8647–8651.
223. Lalvani, A., Hurt, N., Aidoo, M., Kibatala, P., Tanner, M. and Hill, A.V. (1996). Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur. J. Immunol., 26, 773–779.
224. Lanar, D.E., Tine, J.A., de Taisne, C, Seguin, M.C., Cox, W.I., Winslow, J.P. et al. (1996). Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria. Infect. Immun., 64, 1666–1671.
225. Langhorne, J. (1989). The role of CD4+ T-cells in the immune response to Plasmodium chabaudi. Parasitol. Today, 5, 362–364.
226. Langhorne, J., Gillard, S., Simon, B., Slade, S. and Eichmann, K. (1989). Frequencies of CD4+ T cells reactive with Plasmodium chabaudi: distinct response kinetics for cells with Thl and Th2 characteristics during infection. Int. Immunol., 1, 416–424.
227. Langhorne, J., Mombaerts, P. and Tonegawa, S. (1995). Alpha beta and gamma delta T cells in the immune response to the erythrocytic stages of malaria in mice. Int. Immunol., 7,1005–1011.
228. Langhorne, J., Pells, S. and Eichmann, K. (1993). Phenotypic characterizationmiceinfected with Plasmodium chabaudi. Scand. J. Immunol., 38, 521–528.
229. Langhorne, J. and Simon Haarhaus, B. (1991). Differential T cell responses T Plasmodiumchabaudiinperipheral blood and spleens of C57BL/6 mice during infection. J. Immunol., 146, 2771–2775.
230. Leech, J.H., Barnwell, J.W., Miller, L.H. and Howard, R.J.(1984). Identification of a strain-specific malarial antigen exposed on the surface of Plasmodiumfalciparum-infected erythrocytes. J Exp. Med., 159, 1567–1575.
231. Lew, AM., Langford, C.J., Anders, R.F., Kemp, D.J., Saul, A., Fardoulys, C. et al. (1989). A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami. PNAS, 86, 3768–3772.
232. Lewis, A.P. (1989). Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmosium yoelli. Mol. Biochem. Parasitol., 36, 271–282.
233. Li, S., Rodrigues, M., Rodriguez, D., Rodriguez, J.R., Esteban, M., Palese, P. et al. (1993). Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against mal aria. PNAS, 90, 5214–5218.
234. Locher, C.P. and Tam, L.Q. (1993). Reduction of disulfide bonds in Plasmodium falciparum gp!95 abolishes the production of growth-inhibitory antibodies. Vaccine, 11, 1119–1123.
235. Lockyer, M.J., Marsh, K. and Newbold, C.J. (1989). Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. Mol. Biochem. Parasitol., 37, 275–280.
236. Lucas, S.B., Peacock, C.S., Hounnou, A., Brattegaard, K., Koffi, K., Honde, M. et al. (1996). Disease in children infected with HIV in Abidjan, Cote d’Ivoire. BMf, 312, 335–338.
237. Lyon, J.A. and Haynes, J.D. (1986). Plasmodium falciparum anti gens synthesized by sehizonts and stabilized at the merozoite surface when sehizonts mature in the presence of protease inhibitors. J. Immunol., 136, 2245–2251.
238. Lyon, J.A, Haynes, J.D., Diggs, C.L., Chulay, J.D. and Pratt-Rossiter, J.M. (1986). Plasmodium falciparum antigens synthesized by sehizonts and stabilized at the merozoite surface by antibodies when sehizonts mature in the presence of growth inhibitory immune serum. J. Immunol., 136, 2252–2258.
239. Maheshwari, R.K., Srikantan, V, Bhartiya, D., Puri, S.K., Dutta, G.P. and Dhawan, B.N. (1990). Effects of interferon in malaria infection. Imm unol. Lett., 25, 53–58.
240. Majarian, W.R., Daly, TiVL, Weidanz, W.P. and Long, C.A. (1984). Passive immunization against murine malaria with an IgG3 monoclonal antibody. J. Immunol., 132, 3131–3137.
241. Malik, A., Egan, J.E., Houghton, R.A., Sadoff, J.C. and Hoffman, S.L. (1991). Human cytotoxic T lymphocytes against Plasmodium falciparum circumsporozoite protein. PNAS, 88, 3300–3304.
242. Marchand, C. and Druilhe, P. (1990). How to select Plasmodium falciparum pre-erythrocytic antigens in an expression library without defined probe. Bull. World Health Organ., 68(Suppl.), 158–164.
243. Margos, G., Kurtenbaeh, K., Posnett, E., Barker, G.C., Matsuoka, H., Paton, M.G. et al. (1995). Expression of the Plasm odium berghei ookinete protein Pbs21 in a baculovirus-insect cell system produces an efficient transmission blocking immunogen. Parasite Immunol., 17, 167–176.
244. Marsh, K. and Howard, RJ. (1986). Antigens induced on erythrocytes by P falciparum: expression of diverse and conserved determinants. Science, 231, 150–153.
245. Marshall, V.M., Anthony, R.L., Bangs, M.J., Pumomo, Anders, R.F. and Coppel, R.L. (1994). Allelic variants of the Plasm odium falciparum mero zoite surface antigen 2 (MSA-2) in a geographically restricted area of Irian Jaya. Mol. Biochem. Parasitol., 63, 13–21.
246. Marshall, V.M., Coppel, R.L., Anders, R.F. and Kemp, D.J. (1992). Two novel alleles within subfamilies of the merozoite surface antigen-2 (MSA-2) of Plasmodiumfalciparum. Mol. Biochem. Parasitol., 50, 181–184.
247. Marshall, V.M., Peterson, M.G., Lew, AM. and Kemp, D.J. (1989). Structure of the apical membrane antigen I (AMA-1). of Plasmodium chabaudi. Mol. Biochem. Parasitol., 37, 281–283.
248. McBride, J.S. and Heidrich, H.-G. (1987). Fragments of the polymorphic Mr 185, 000 glycoprotein from the surface of isolated Plasmodiumfalciparum merozoites form an antigenic complex. Mol. Biochem. Parasitol, 23, 71–84.
249. McColl, DJ., Silva, A., Foley, M., Kun, J.K.J., Favaloro, J.M., Thompson, J.K. et al. (1994). Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites. Mol. Biochem. Parasitol., 68, 53–67.
250. McCutchan, T.F., Kissinger, J.C., Touray, M.G., Rogers, MJ., Li, J., Sullivan, M. et al. (1996). Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. PNAS, 93, 11889–11894.
251. McDonald, V and Phillips, R.S. (1978). Plasmodium chabaudi in mice. Adoptive transfer of immunity with enriched populations of spleen T and B lymphocytes. Immunology, 35, 821–830.
252. McGregor, LA and Carrington, S.P. (1963). Treatment of East African P. falciparum malaria with West African human gamma-globulin. Trans. Roy. Soc. Trop. Med. Hyg., 57–3, 170–175.
253. McGregor, I.A. (1964). The passive transfer of human malarial immunity. Am. J. Trop. Med. Hyg., 13, 237–239.
254. McGregor, LA and Smith, D.A. (1952). A health, nutrition and parasitological survay in a rural village (Keneba) in West Kiang, Gambia. Trans. Roy. Soc. Trop. Med. Hyg., 46, 403–427.
255. Mellouk, S., Berbiguier, N., Druilhe, P., Sedegah, M., Galey, B., Yuan, L. et al. (1990). Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull. World Health Organ., 68 (Suppl), 52–59.
256. Mellouk, S., Green, S.J., Nacy, C.A and Hoffman, S.L. (1991). IFN-y inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol., 146, 3971–3976.
257. Mellouk, S., Hoffman, S.L., Liu, Z.Z., De la Vega, P., Billiar, T.R. and Nussler, A.K. (1994). Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by exogenous tetrahydrobiopterin. Infect. Immun., 62, 4043–4046.
258. Mcllouk, S., Mahcshwari, R.K., Rhodes-Feuillette, A., Beaudoin, R.L., Berbiguier, N., Matile, H. et al. (1987). Inhibitory activity of interferons and interleukin 1 on the development of Plasmodiumfalciparum in human hepatocyte cultures. J. Immunol., 139, 4192–4195.
259. Menard, R., Sultan, A.A., Cortes, C., Altszuler, R., van Dijk, M.R., Janse, C.J. et al. (1997). Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes. Nature, 385, 336–340.
260. Mendis, K.N., Munesinghe, YD., De Silva, YN.Y, Keragalla, I. and Carter, R. (1987). Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans. Infect. Immun., 55, 369–372.
261. Miller, KL, Silverman, P.H., Kullgren, B. and Mahlmann, L.J. (1989). Tumor necrosis factor alpha and the anemia associated with murine mal aria. Infect. Immun., 57, 1542–1546.
262. Miller, L.H., Roberts, T, Shahabuddin, M. and McCutchan, T.F. (1993). Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol., 59, 1–14.
263. Moelans, J.J., Cohen, J., Marchand, M., Molitor, C., de Wilde, P., van Pelt, J.F. et al. (1995). Induction of Plasmodium falciparum sporozoite-neutralizing antibodies upon vaccination with recombinant Pfs16 vaccinia virus and/or recombinant Pfsl6 protein produced in yeast. Mol. Biochem. Parasitol., 72, 179–192.
264. Moelans, J.J., Meis, IF, Kocken, C., Konings, R.N. and Schoenmakers, J.G. (1991). A novel protein antigen of the malaria parasite Plasmodium falciparum, located on the surface of gametes and sporozoites. Mol. Biochem. Parasitol., 45, 193–204.
265. Mor, G., Klinman, D.M., Shapiro, S., Hagiwara, E., Sedegah, M., Norman, J.A. et al. (1995). Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J. Immunol., 155, 2039–2046.
266. Moreno, A., Clavijo, P., Edelman, R., Davis, J., Sztein, M., Herrington, D. et al. (1991). Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. Int. Immunol., 3, 997–1003.
267. Moreno, A., Clavijo, P., Edelman, R., Davis, J., Sztein, M., Sinigaglia, F. et al. (1993). CD4+ T cell clones obtained from Plasmodiumfalciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. J. Immunol., 151, 489–499.
268. Mulhern, T.D., Howlett, GJ., Reid, G.E., Simpson, R.J., McColl, D.J., Anders, R.F. et al. (1995). Solution structure of a polypeptide containing four heptad repeat units from a merozoite surface antigen of Plasmodium falciparum. Biochemistry, 34, 3479–3491.
269. Muller, H.M., Reckmann, L, Hollingdale, M.R., Bujard, H., Robson, K.J. and Crisanti, A. (1993). Thrombospondin related anonymous protein (TRAP) of Plasmodiumfalciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J., 12, 2881–2889.
270. Muller, H.M., Scarselli, E. and Crisanti, A. (1993). Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum in parasite-host cell interactions. Parassitologia, 35 Suppl, 69–72.
271. Muller, O. and Moser, R, (1990). The clinical and parasitological presentation of Plasmodiumfalciparum malaria in Uganda is unaffected by HIV-l infection. Trans. Roy. Soc. Trop. Med. Hyg., 84, 336–338.
272. Naotunne, T.D.S., Karuna Weera, N.D., Del Giudiee, G., Kularatne, M.U., Grau, G.E., Carter, R. et al. (1991). Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential, J. Exp. Med., 173, 523–529.
273. Nardin, E.H., Nussenzweig, V, Nussenzweig, R.S., Collins, W.E., Harinasuta, K.T., Tapchaisri, P. et al. (1982). Circumsporozoite proteins of human malaria parasites Plasmodium falciparum 'Uld Plasmodium vivax. J. Exp. Med., 156, 20–30.
274. Narum, D.L. and Thomas, A.W. (1994), Differential localization of full-length and processed fonns of PF83/AMA-1 an apical membrane antigen of Plasmodium falcip arum merozoites. Mol. Biochem. Parasitol., 67, 59–68.
275. Niyongabo, T, Deloron, P., Aubry, P., Ndarugirire, E, Manirakiza, F., Muhirwa, G. et al. (1994). Prognostic indicators in adult cerebral malaria: a study in Burundi, an area of high prevalence of HIV infection. Acta Trop., 56, 299–305.
276. Nussenzweig, R.S., Vanderberg, J., Most, H. and Orton, C. (1967). Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature, 216, 160–162.
277. Ockenhouse, C.F., Klotz, F.W., Tandon, N.N. and Jamieson, G.A. (1991). Sequestrin, a CD36 recognition protein on Plasmodium falciparum malaria-infected erythrocytes identified by anti-idiotype antibodies. PNAS, 88, 3175–3179.
278. Oeuvray, C, Bouharoun Tayoun, H., Gras Masse, H., Bottius, E., Kaidoh, T., Aikawa, M. et al. (1994a). Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood, 84, 1594–1602.
279. Oeuvray, C, Bouharoun Tayoun, H., Grass Masse, H., Lepers, J.P., Ralamboranto, L., Tartar, A. et al. (1994b). A novel merozoite surface antigen of Plasmodium falciparum (MSP-3). identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies. Mem. Inst. Oswaldo. Cruz., 89 Suppl 2, 77–80.
280. Pancake, S.J., Holt, G.D., Mellouk, S. and Hoffman, S.L. (1992). Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates. J.Cell Biol., 117, 1351–1357.
281. Panina Bordignon, P., Tan, A, Termijtelen, A., Demotz, S., Corradin, G. and Lanzavecchia, A. (1989). Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol., 19, 2237–2242.
282. Patarroyo, M.E., Amador, R., Clavijo, P., Moreno, A, Guzman, F, Romero, P. et al. (1988). A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 158–161.
283. Perkins, M.E. and Rocco, L.J. (1988). Sialic acid-dependent binding of Plasmodium falciparum merozoite surface antigen, Pf200, to human erythrocytes. J. Immunol., 141, 3190–3196.
284. Perlmann, H., Perlmann, P., Berzins, K., Wahlin, B., Troye Blomberg, M., Hagstedt, M. et al. (1989). Dissection of the human antibody response to the malaria antigen Pf 155/RES A into epitope specific components. Immunol, Rev., 112, 115–132.
285. Perrin, L.H., Merkli, B., Loche, M., Chizzolini, C, Smart, J. and Richie, R. (1984). Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages. J. Exp. Med., 160, 441–451.
286. Perrin, L.H., Ramirez, E., Lambert, P.H. and Miescher, P.A (1981). Inhibition of P falciparum growth in human erythrocytes by monoclonal antibodies. Nature, 289, 301–303.
287. Petersen, E., Hogh, B., Marbiah, N.T., Perlmann, H., Wilcox, M., Dolopaie, E. et al. (1990). A longitudinal study of antibodies to the Plasmodium falciparum antigen Pf155/RESA an immunity to infection in adult Liberians. Trans. Roy. Soc. Trop. Med. Hyg., 84, 339–345.
288. Peterson, M.G., Marshall, V.M., Smythe, J.A., Crewther, P.E., Lew, A, Silva, A. et al.(1989). Integral membrane protein located in the apical complex of Plasmodium falciparum. Mol. Cell. Biol., 9, 3151–3154.
289. Peterson, M.G., Nguyendinh, P., Marshall, V.M., Elliot, J.F., Collins, W.E., Anders, R.F et al. (1990). Apical membrane antigen of Plasmodium fragile. Mol. Biochem. Parasitol., 39, 279–284.
290. Pied, S., Renia, L., Nussler, A., Miltgen, F and Mazier, D. (1991). Inhibitory activity of IL-6 on malaria hepatic stages. Parasite Immunol., 13, 211–217.
291. Playfair, J.H.L. (1996). An antitoxic vaccine for malaria? In: Hoffman, S.L., (Ed.). Malaria Vaccine Development: A Multi-Immune Response Approach, pp. 167–179. Washington, DC: American Society for Microbiology.
292. Podoba, J.E. and Stevenson, M.M. (1991). CD4+ and CD8+ T lymphocytes both contribute to acquired immunity to blood stage Plasmodium chabaudi AS. Infect. Immun., 59, 51–58.
293. Ponnudurai, T., Van Gemert, G.J., Bensink, T., Lensen, AH. and Meuwissen, J.H. (1987). Transmission blockade of Plasmodium falciparum: its variability with gametocyte numbers and concentration of antibody. Trans. Roy. Soc. Trop. Med. Hyg., 81, 491–493.
294. Potocnjak, P., Yoshida, N., Nussenzweig, R.S. and Nussenzweig, V. (1980). Mg'ivalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malaria infection. J. Exp. Med., 151, 1504–1513.
295. Premawansa, S., Gamage Mendis, A, Perera, L., Begarnie, S., Mendis, K. and Carter, R. (1994). Plasmodium falciparum malaria transmission blocking immunity under conditions of low endemicity as in Sri Lanka. Parasite Immunol., 16, 35–42.
296. Pye, D., Edwards, S.J., Anders, R.F, O’Brien, C.M., Franchina, P., Corcoran, L.N. et al. (1991). Failure of recombinant vaccinia viruses expressing Plasmodium falciparum anti gens to protect Saimiri monkeys against malaria. Infect. Immun., 59, 2403–2411.
297. Quakyi, I.A., Carter, R, Rener, J., Kumar, N., Good, M. and Miller, L.H. (1987). The 230-kDa gamete surface protein of Plasmodium falcip arum is also a target for transmission-blocking antibodies. J. Immunol., 139, 4213–4217.
298. Quakyi, LA., Otoo, L.N., Pombo, D., Sugars, L.Y, Menon, A., DeGroot, A.S. et al. (1989). Differential nonresponsiveness in humans of candidate Plasmodiumfalciparum vaccine antigens. Am. J. Trop. Med. Hyg., 41, 125–134.
299. Ramasamy, R., Jones, G. and Lord, R. (1990). Characterisation of an inhibitory monoclonal antibody defined epitope on a malaria vaccine candidate antigen. Imm unol. Lett., 223, 305–310.
300. Ramsey, J.M., Salinas, E., Rodriguez, M.H. and Beaudoin, R.L. (1994). Effects of transmission blocking immunity on Plasmodium vivax infections in Anopheles albimamis populations. J. Parasitol., 80, 88–92.
301. Ranawaka, M.B., Munesinghe, YD., de Silva, D.M., Carter, R. and Mendis, K.N. (1988). Boosting of transmission blocking immunity during natural Plasmodium vivax infections in humans depends upon frequent reinfection. Infect. Immun., 56, 1820–1824.
302. Reed, R.C., Louis-Wileman, V, Cosmai, E.V., Fang, S., Jue, D.L., Wohlhueter, R.M. et al. (1997). Multiple antigen constructs (MACS): induction of-sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii. Vaccine, 15, 482–488.
303. Reeder, J.C., Davern, K.M., Baird, J.K., Rogerson, S.J. and Brown, G.V. (1997). The age-specific prevalence of Plasmodiumfalciparum in migrants to Irian Jaya is not attributable to agglutinating antibody repertoire. Acta Trop., 65, 163–173.
304. Rener, J., Carter, R., Rosenberg, Y and Miller, L.H. (1980). Anti-gamete monoclonal antibodies synergistieally block transmission of malaria by preventing fertilization in the mosquito. PNAS, 77, 6797–6799.
305. Renggli, J., Hahne, M., Matile, H., Betschart, B., Tschopp, J. and Corradin, G. (1997). Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-l) or perforin mediated cytotoxicity. Parasite Immunol., 19, 145–148.
306. Richards, W.G.H. (1966). Active immunization of chicks against Plasmodium gallinacium by inactivated homologous sporozoites and erythrocytic parasites. Nature, 212, 1492–1494.
307. Rickman, L.S., Gordon, D.M., Wistar, R., Krzych, U., Gross, M., Hollingdale, M.R. et al. (1991). Use ofadjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine. Lancet, 337, 998–1001.
308. Ridley, R.G., Lahm, H., Takacs, B. and Scaife, J.G. (1991). Genetic and structural relationships between components of a protective rhoptry antigen complex from Plasmodiumfalciparum. Mol. Biochem. Parasitol., 47, 245–246.
309. Ridley, R.G., Takacs, B., Etlinger, H. and Scaife, J.G. (1990a). A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys. Parasitology, 101, 187–192.
310. Ridley, R.G., Takacs, B., Lahm, H., Delves, C.J., Goman, M., Certa, U. et al. (1990b). Characterisation and sequence of a protective rhoptry antigen from Plasmodium falciparum. Mol. Biochem. Parasitol., 41, 125–134.
311. Rieckmann, K.H., Beaudoin, RL., Cassells, J.S. and Sell, D.W.(1979). Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull. World Health Organ., 57(Suppl. 1), 261–265.
312. Rieckmann, K.H., Carson, P.E., Beaudoin, R.L., Cassells, J.S. and Sell, K.W. (1974). Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans. Roy. Soc. Trop. Med. Hyg., 68, 258–259.
313. Riley, E.M., Allen, S.J., Troye Blomberg, M., Bennett, S., Perlmann, H., Andersson, G. et al. (1991). Association between immune recognition of the malaria vaccine candidate antigen Pf155 m, ESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa. Trans. Roy. Soc. Trop. Med. Hyg., 85, 436--443.
314. Riley, E.M., Allen, S.J., Wheeler, J.G., Blackman, M.J., Bennett, S., Takacs, B. et al. (1992). Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (P1MSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol., 14, 321–337.
315. Riley, E.M., Morris-Jones, S., Blackman, M.J., Greenwood, B.M. and Holder, A.A. (1993). A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP'1) of Plasmodium falcip arum in an area of seasonal malaria transmission. Parasite Immunol., 15, 513–524.
316. Roberts, D.W, and Weidanz, W.P. (1979). T-cell immunity to malaria in the B-cell deficient mouse. Am. J. Trop. Med. Hyg., 28, 1–3.
317. Robson, K.J., Frevert, U., Reckmann, I., Cowan, G., Beier, J., Scragg, I.G. et al. (1995). Thrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: expression during sporozoite ontogeny and binding to human hepatocytes. EMBO J., 14, 3883–3894.
318. Robson, K.J., Hall, J.R., Davies, L.C., Crisanti, A, Hill, A.V. and Wellems, T.E. (1990). Polymorphism of the TRAP gene of Plasmodium falciparum. Proc. R. Soc. Lond. B. Biol. Sci., 242, 205–216.
319. Robson, K.J., Hall, J.R., Jennings, M.W., Harris, T.J., Marsh, K., Newbold, C.I. et al. (1988). A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature, 335. 79–82.
320. Robson, K.J.H., Naitza, S., Barker, G., Sinden, R.E. and Crisanti, A. (1997). Cloning and expression of the thrombospondin related adhesive protein gene of Plasmodium berghei. Mol. Biochem. Parasitol., 84, 1–12.
321. Rodrigues, E.G., Zavala, F., Eichinger, D., Wilson, J.M. and Tsuji, M. (1997). Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J. Immunol., 158, 1268–1274.
322. Rodrigues, M., Nussenzweig, R.S., Romero, P. and Zavala, F. (1992). The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J. Exp. Med., 175, 895–905.
323. Rodrigues, M., Nussenzweig, R.S. and Zavala, F. (1993). The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology, 80, 1–5.
324. Rodrigues, M.M., Cordey, A-S., Arreaza, G., Corradin, G., Romero, P., Maryanski, J.L. et al. (1991). CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol., 3, 579–585.
325. Roeffen, W., Geeraedts, E, Eling, W., Beckers, P., Kumar, N., Lensen, T. et al. (1995). Transmission blockade of Plasmodiumfalciparum malaria by anti-Pfs230-specific antibodies is isotype dependent. Infect. Immun., 63, 467–471.
326. Roeffen, W., Mulder, B., Teelen, K., Bolmer, M., Eling, W., Targett, G.A.T. et al. (1996). Association between anti-Pfs48/45 reactivity and P. falciparum transmission blocking activity in SERA from Cameroon. Parasite Immunol., 18, 103–109.
327. Rogers, W.O., Malik, A, Mellouk, S., Nakamura, K., Rogers, M.D., Szarfman, A. et al. (1992a). Characterization of Plasmodium falciparum sporozoite surface protein 2. PNAS, 89, 9176–9180.
328. Rogers, W.O., Rogers, M.D., Hedstrom, R.C. and Hoffman, S.L. (1992b). Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodiumyoelii sporozoite antigen. Mol. Biochem. Parasitol., 53, 45–52.
329. Romero, P., Maryanski, J.L., Corradin, G., Nussenzweig, R.S., Nussenzweig, V. and Zavala, F. (1989). Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature, 341, 323–325.
330. Roussilhon, C., Agrapart, M., Guglielmi, P., Bensussan, A, Brasseur, P. and Ballet, J.J. (1994). Human TcR gamma delta+ lymphocyte response on primary exposure to Plasmodium falciparum. Clin. Exp. Immunol., 95, 91–97.
331. Ruangjirachupom, W., Udomsangpetch, R., Carlsson, J., Drenckhahn, D., Perlmann, P. and Berzins, K. (1991). Plasmodium falciparum: anal ysis of the interaction of antigen Pf 155/RES A with the erythrocyte membrane. Exp. Parasitol., 73, 62–72.
332. Russell, P.F., Mulligan, H.W. and Mohan, B.N. (1941). Specific agglutinogenic properties of inactivated sporozoites of P. gallinaceum. J. Mal. Inst. India, 4, 15–19.
333. Sabchareon, A., Burnouf, T., Ouattara, D., Attanath, P., Bouharoun Tayoun, H., Chantavanieh, P. et al. (1991). Parasitologic and clinical human response to immunoglobulin administration in falciparum mal aria. Am. I. Trop. Med. Hyg., 45, 297–308.
334. Sadoff, J.C., Ballou, W.R, Baron, L.S., Majarian, W.R., Brey, R.N., Hockmeyer, W.T. et al. (1988). Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science, 240, 336–338.
335. Sanchez, G.I., Rogers, W.O., Mellouk, S. and Hoffman, S.L. (1994). Plasmodiumfalciparum: exported protein-1, a blood stage antigen, is expressed in liver stage parasites. Exp. Parasitol., 79, 59–62.
336. Santoro, F., Cochrane, AH., Nussenzweig, V, Nardin, E.H., Nussenzweig, R.S., Gwadz, R.W. et al. (1983). Structural similarities among the protective antigens of sporozoites from different species of malaria parasites. J Biol. Chem., 258(5), 3341–3345.
337. Saul, A.(1996). Transmission dynamics of Plasmodium falciparum. Parasitol. Today, 12, 74–82.
338. Saul, A., Lord, R., Jones, G.L. and Spencer, L. (1992). Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2. J. Immunol., 148, 208–211.
339. Saul, A.J., Cooper, D., Hauquitz, D., Irving, D., Cheng, Q., Stowers, A. et al. (1992). The 42-kilodalton rhoptry associated protein of Plasmodium falciparum. Mol. Biochem. Parasitol., 50, 139–150.
340. Sayles, P.C. and Rakhmilevich, L. (1996). Exacerbation of Plasmodium chabaudi malaria in mice by depletion of TCR alpha beta+ T cells, but not TCR gamma delta+ T cells. Immunology, 87, 29–33.
341. Scarselli, E., Tolle, R., Koita, O., Diallo, M., Muller, H.M., Fruh, K. et al. (1993), Analysis of the human antibody response to thrombospondin-related anonymous protein of Plasmodium falciparum. Infect. Immun., 61, 3490–3495.
342. Scheller, L.F. and Azad, A.F. (1995). Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. PNAS, 92, 4066–4068.
343. Schofield, L., Bushell, G.R., Cooper, J.A., Saul, A.J., Upcroft, J.A. and Kidson, C. (1986). A rhoptry antigen of Plasmodium falciparum contains conserved and variable epitopes recognised by inhibitory monoclonal antibodies. Mol. Biochem. Parasitol., 18, 183–195.
344. Schofield, L. and Hackett, F. (1993). Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J. Exp. Med., 177, 145–153.
345. Schofield, L., Novakovic, S., Gerold, P., Schwarz, R.T., McConville, MJ. and Tachado, S. (1996). Glycophosphatidylinositol toxin of Plasmodium upregulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J. Immunol., 156, 1886–1896.
346. Schofield, L., Villaquiran, J., Ferreira, A., Schellekens, H., Nussenzweig, R.S. and Nussenzweig, V. (1987). Gamma-interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature, 330, 664–666.
347. Sedegah, M., Beaudoin, R.L., De la Vega, P., Leef, M.F., Ozcel, M.A., Jones, E. et al. (1988). Use of a vaccinia construct expressing the circumsporozoite protein in the analysis of protective immunity to Plasmodium yoelii. In: Lasky, L., (Ed.). Technological advances in vaccine development, pp. 295–309. New York: Alan R. Liss, Inc.
348. Sedegah, M., Beaudoin, R.L., Majarian, W.R., Cochran, M.D., Chiang, C.H., Sadoff, J. et al. (1990). Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia, pseudorabies, and salmonella transformed with circumsporozoite gene. Bull. World Health Organ., 68(Suppl.), 109–114.
349. Sedegah, M., Chiang, C.H., Weiss, W.R., Mellouk, S., Cochran, M.D., Houghton, R.A. et al. (1992). Recombinant pseudorabies virus carrying a plasmodium gene: herpes virus as a new live viral vector for inducing T- and B-cell immunity. Vaccine, 10, 578–584.
350. Sedegah, M, Finkelman, F. and Hoffman, S.L. (1994). Interleukin-12 induction ofinterferon gamma-dependent protection against malaria. PNAS, 91, 10700–10702.
351. Sedegah, M., Hedstrom, R., Hobart, P. and Hoffman, S.L. (1994). Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. PNAS, 91, 9866–9870.
352. Sedegah, M., Jones, T.R., Kaur, M., Hedstrom, R., Hobart, P., Tine, J.A. and Hoffman, S.L. (1998). Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of a malaria DNA vaccine. Proc. Natl. Acad. Sci. USA, 95, 7648–7653.
353. Seguin, M.C., Klotz, F.W., Schneider, I., Weir, J.P., Goodbary, M., Slayter, M. et al. (1994). Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J. Exp. Med., 180, 353–358.
354. Shi, Y.P., Alpers, M.P., Povoa, M.M. and Lal, A.A. (1992). Diversity in the immunodominant determinants of the circumsporozoite protein of Plasmodium falciparum parasites from malaria-endemic regions of Papua'New Guinea and Brazil. Am. J. Trop. Med. Hyg., 47, 844–851.
355. Shi, Y.P., Sayed, U., Qari, S.H., Roberts, J.M., Udhayakumar, V., Oloo, AJ. et al. (1996). Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect. Immun., 64, 2716–2723.
356. Siddiqui, W.A., Tam, L., Kan, S.-C., Kramer, K.J., Case, S.E., Palmer, K.L. et al. (1986). Induction of protective immuity to monoclonal antibody-defined Plasmodium falciparum antigens required a strong adjuvant in Aotus monkeys. Infect. Immun., 52, 314–318.
357. Siddiqui, W.A., Tam, L.Q., Kramer, K.J., Hui, G.S., Case, S.E., Yamaga, K.M. et al. (1987). Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodiumfalciparum malaria. PNAS, 84, 3014–3018.
358. Sim, B.K.L. (1995). EBA-175: an erythrocyte-binding ligand of Plasmodiumfalciparum. Parasitol. Today, 11, 213–217.
359. Sim, B.K.L., Carter, J.M., Deal, C.D., Holland, C., Haynes, J.D. and Gross, M. (1994a). Plasmodiumfalciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175. Exp. Parasitol., 78, 259–268.
360. Sim, B.K.L., Chitnis, CE., Wasniowska, K., Hadley, TJ. and Miller, L.H.(1994b). Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science, 264, 1941–1944.
361. Sim, B.K.L., Orlandi, P.A., Haynes, J.D., Klotz, EW., Carter, J.M., Camus, D. et al. (1990). Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J. Cell Biol., 111, 1877–1884.
362. Sinigaglia, E, Matile, H. and Pink, J.R. (1987). Plasmodiumfalciparum-specific human T cell clones: evidence for helper and cytotoxic activities. Eur. J. Immunol., 17, 187–192.
363. Sinton, J.A. (1939). A summary of our present knowledge of the mechanism of immunity in malaria. J. Mill. Inst. India, 2, 71–83.
364. Sinton, J.A. and Singh, J-J. (1931). The numerical prevalence of parasites in relation to fever in chronic benign tertian malaria. Indian J. Med. Res., 18, 871–879.
365. Smith, J.D., Chitnis, C.E., Craig, A.G., Roberts, D.J., HudsonTaylor, D.E., Peterson, D.S. et al. (1995). Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell, 82, 101–110.
366. Smythe, J.A, Coppel, R.L., Day, K.P, Martin, R.K., Oduola, A.M.J., Kemp, D.J. et al. (1991). Structural diversity in the Plasmodium falciparum merozoite surface antigen-2. PNAS, 88, 1751–1755.
367. Smythe, J.A., Peterson, M.G., Coppel, R.L., Saul, A.J., Kemp, D.J. and Anders, R.E. (1990). Structural diversity in the 45-kD merozoite surface antigen of Plasmodium falciparum. Mol. Biochem. Parasitol., 39, 227–234.
368. Snewin, VA., Herrera, M., Sanchez, G., Scherf, A., Langsley, G. and Herrera, S.(1991). Polymorphism of the alleles of the merozoite surface antigens MSA I and MSA2 in Plasmodium falciparum wild isolates from Colombia. Mol. Biochem. Parasitol., 49, 265–276.
369. Snow, RW., Omumbo, J.A., Lowe, B., Molyneux, C.S., Obiero, J.O., Palmer, A. et al. (1997). Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet, 349, 1650–1654.
370. Southwell, B., Brown, G.V, Forsyth, K.P, Smith, T., Philip, G. and Anders, R.E. (1989). Field applications of agglutination and cytoadherence assays with Plasmodiumfalciparum from Papua New Guinea. Trans. Roy. Soc. Trop. Med. Hyg., 83, 4644–69.
371. Steketee, RW., Wirima, J.J., Bloland, PB., Chilima, B., Mermin, J.H., Chitsulo, L. et al. (1996a). Impairment of a pregnant woman’s acquired ability to limit Plasmodium falciparum by infection with human immuodeficiency virus type-1. Am. J. Trop. Med. Hyg., 55(1 Suppl), 42–49.
372. Steketee, R.W, Wirima, J.J., Slutsker, L., Roberts, J.M., Khoromana, C.O., Heymann, D.L. et al. (1996b). Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi. Am. J. Trop. Med. Hyg., 55(1 Suppl.), 24–32.
373. Stoute, J.A., Slaoui, M., Heppner, D.G., Momin, P., Kester, K.E., Desmons, P. et al. (1997). A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N. Engl. J. Med., 336, 86–91.
374. Stowers, A., Taylor, D., Prescott, N., Cheng, Q., Cooper, J. and Saul, A. (1997). Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2. Infect. Immun., 65, 2329–2338.
375. Stowers, A.W., Cooper, J.A, Erhardt, T. and Saul, A. (1996). A peptide derived from a B cell epitope of Plasmodium falciparum rhoptry associated protein 2 specifically raises antibodies to rhoptry associated protein 1. Mol. Biochem. Parasitol., 82, 167–180.
376. Su, S., Sanadi, A.R., Ifon, E. and Davidson, E.A. (1993). A monoclonal antibody capable of blocking the binding of Pf200 (MSA-1) to human erythrocytes and inhibiting the invasion of Plasmodiumfalciparum merozoites into human erythrocytes. J. Immunol., 151, 2309–2317.
377. Su, X.Z., Heatwole, VM., Wertheimer, S.P., Guinet, E, Herrfeldt, J.A., Peterson, D.S. et al. (1995). The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell, 82, 89–100.
378. Sultan, AA, Thathy, V., Frevert, U., Robson, K.J.H., Crisanti, A., Nussenzweig, V. et al. (1997). TRAP is necessary for gliding motility and infectivity of Plasmodium sporozoites. Cell, 90, 511–522.
379. Suss, G., Eichmann, K., Kury, E., Linke, A. and Langhorne, J. (1988). Roles of CD4- and CD8-bearing T lymphocytes in the immune response to the erythrocytic stages of Plasmodium chabaudi. Infect. Immun., 56, 3081–3088.
380. Szarfman, A, Lyon, J.A, Walliker, D., Quakyi, I., Howard, R.J., Sun, S. et al. (1988a). Mature liver stages of cloned Plasmodiumfalciparum share epitopes with proteins from sporozoites and asexual blood stages. Parasite Immunol., 10, 339–351.
381. Szarfman, A, Walliker, D., McBride, J.S., Lyon, J.A, Quakyi, LA and Carter, R. (1988b). Allelic forms of gp 195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages. J. Exp. Med., 167, 231–236.
382. Tachado, S., Gerold, P., McConville, M.J., Baldwin, T., Quilici, D., Schwarz, R.T. et al. (1996). Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J. Immunol., 156, 1897–1907.
383. Tachado, S., Gerold, P., Schwarz, R., Novakovic, S., McConville, M. and Schofield, L. (1997). Signal transduction in macrophages by glycosylphosohatidyl inositols of Plasmodium, Trypanosoma, and Leishmania: Activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. PNAS, 94, 4022–4027.
384. Tam, J.P, Clavijo, P., Lu, Y, Nussenzweig, V., Nussenzweig, R. and Zavala, E. (1990). Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med., 171, 299–306.
385. Tanabe, K., Mackay, M., Goman, M. and Scaife, J.G. (1987). Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J. Mol. Biol., 195, 273–287.
386. Taverne, J., Bate, C.A.W., Kwiatowski, D., Jakobsen, PH. and Playfair, J.H.L. (1990). Two soluble antigens of P. falciparum induce TNF release from macrophages. Infect. Immun., 58, 2923–2928.
387. Taylor Robinson, A.W. and Phillips, R.S. (1994). Thl and Th2 CD4+ T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection. Eur. J. Immunol., 24, 158–164.
388. Taylor Robinson, AW., Phillips, R.S., Severn, A, Moncada, S. and Liew, E.Y. (1993). The role of THI and TH2 cells in a rodent malaria infection. Science, 260, 1931–1934.
389. Taylor, K., Carr, R., Playfair, J.H.L. and Saggerson, E.D. (1992a). Malaria toxic antigens synergistically enhance insulin signalling. FEBS Lett., 311, 231–234.
390. Taylor, T.E., Molyneux, M.E., Wirima, J.J., Borgstein, A., Goldring, J.D. and Hommel, M. (1992b). Intravenous immunoglobulin in the treatment of paediatric cerebral malaria. Clin. Exp. Immunol., 90, 357–362.
391. Templeton, TJ. and Kaslow, D.C. (1997). Cloning and cross-species comparison of the Thrombospondin-related anonymous protein (TRAP) gene from Plasmodium knowlesi, Plasmodium vivax, and Plasmodium gallinaceum. Mol. Biochem. Parasitol., 84, 13–25.
392. Theander, T.G., Bygbjerg, I.C., Andersen, B.J., Jepsen, S., Kharazmi, A and Odum, N. (1986). Suppression of parasite-specific response in Plasmodium falciparum malaria. A longitudinal study of blood mononuclear cell proliferation and subset composition. Scand. J. Immunol., 24, 73–81.
393. Thomas, A.W., Carr, D.A., Carter, J.M. and Lyon, J.A. (1990). Sequence comparison of allelic forms of the Plasmodium falciparum merozoite surface antigen MSA2. Mol. Biochem. Parasitol., 43, 211–220.
394. Thomas, A.W., Deans, J.A, Mitchell, G.H., Alderson, T. and Cohen, S. (1984). The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes. Mol. Biochem. Parasitol., 13, 187–199.
395. Thomas, A.W., Trape, J.F., Rogier, C., Goncalves, A, Rosario, V.E. and Narum, D.L. (1994). High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-l) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1. Am. J. Trop. Med. Hyg., 51, 730–740.
396. Thomas, A.W., Waters, A.P. and Carr, D. (1990). Analysis of variation in Pf83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium falciparum. Mol. Biochem. Parasitol., 42, 285–287.
397. Troye-Blomberg, M. and Perlmann, P.(1994). Malaria immunity: an overview with emphasis on T cell functions. In: Good, M.E and Saul, A.J., (Eds.). Molecular Considerations in Malaria Vaccine Development, pp. 1–46 Boca Raton: CRC Press.
398. Tsuji, M., Miyahira, Y, Nussenzweig, R.S., Aguet, M., Reichel, M. and Zavala, F. (1995). Development of antimalaria immunity in mice lacking IFN-gamma receptor. J. Immunol., 154, 5338–5344.
399. Tsuji, M., Mombaerts, P., Lefrancois, L., Nussenzweig, R.S., Zavala, F. and Tonegawa, S. (1994). Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. PNAS, 91, 345–349.
400. Tsuji, M., Romero, P., Nussenzweig, R.S. and Zavala, F. (1990). CD4+ cytolytic T cell clone confers protection against murine malaria. J. Exp. Me cl., 172, 1353–1357.
401. Udhayakumar, v., Shi, Y.P., Kumar, S., Jue, D.L., Wohlhueter, R.M. and Lal, A.A. (1994). Antigenic diversity in the circumsporozoite protein of Plasmodium falciparum abrogates cytotoxic T-cell recognition. Infect. Immun., 62, 1410–1413.
402. Valmori, D., Pessi, A., Bianchi, E. and Corradin, G. (1992). Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immunol. Methods, 149, 717–721.
403. van der Heyde, H.C., Elloso, M.M., Chang, W.L., Kaplan, M., Manning, D.D. and Weidanz, W.P. (1995). Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria. J. Immunol., 154, 3985–3990.
404. van der Heyde, H.C., Elloso, M.M., Chang, WL., Pepper, B.J., Batchelder, J. and Weidanz, WP. (1996). Expansion of the gamma delta T cell subsetduring blood stage malaria in B cell deficient mice. J.Leukoc.Biol, 60, 221–229.
405. van der Heyde, H.C., Elloso, M.M., Roopenian, D.C., Manning, D.D. and Weidanz, W.P. (1993a). Expansion of the CD4-, CD8-gamma delta T cell subset in the spleens of mice during non-lethal blood stage malaria. Eur. J. Immunol., 23, 1846–1850.
406. 0/0 mice. J. Immunol., 151, 3187–3191.
407. Vanderberg, J., Nussenzweig, R. and Most, H. (1969). Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites. Mil. Med., 134, 1183–1190.
408. Verhave, J.P., Strickland, G.T., Jaffe, H.A. and Ahmed, A. (1978). Studies on the transfer of protective immunity with lymphoid cells from mice immune to malaria sporozoites. J. Immunol., 121, 1031–1033.
409. Vermeulen, A.N., Ponnudurai, T., Beckers, P.J.A., Verhave, J.P., Smits, M.A. and Meuwissen, J.H. (1985). Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J. Exp. Med., 162, 1460–1472.
410. Vermeulen, A.N., van Deursen, J., Brakenhoff, R.H., Lensen, T.H., Ponnudurai, T. and Meuwissen, J.H. (1986). Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures. Mol. Biochem. Parasitol., 20, 155–163.
411. Voller, A. and Rossan, R.N. (1969). Immunological studies on simian malaria. III. Immunity to challenge and antigenic variation in P knowlesi. Tram. Roy. Soc. Trop. Med. Hyg., 63, 507–523.
412. von der Weid, T., Honarvar, N. and Langhorne, J. (1996). Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J. Immunol., 156, 2510–2516.
413. von der Weid, T. and Langhorne, J. (1993). Altered response of CD4+ subsets to Plasmodium chabaudi in B cell-deficient mice. Int. Immunol., 5, 1343–1348.
414. Wahlin, B., Berzins, K., Perlmann, H., Anders, R.F. and Perlmann, P. (1990). Anti-idiotype antibodies counteract the invasion inhibition capacity of antibodies to major epitopes of the Plasm odium falciparum antigen Pf 155/RES A. Infect. Immun., 58, 2815–2820.
415. Wang, H.H., Rogers, W.O., Kang, Y.H., Sedegah, M. and Hoffman, S.L. (1995a). Partial protection against malaria by immunization with Leishmania enrietti expressing the Plasmodium yoelii circumsporozoite protein. Mol. Biochem. Parasitol., 69, 139–148.
416. Wang, R., Charoenvit, Y, Corradin, G., Porrozzi, R., Hunter, R.L., Glenn, G. et al. (1995b). Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. J. Immunol., 154, 2784–2793.
417. Wang, R., Doolan, D.L., Charoevit, Y, Hedstrom, R.C., Gardner, MJ., Hobart, P, Tine, J., Sedegah, M., Fallarme, V., Sacci, J.B., Jr., Kaur, M., Klinman, D.M., Hoffman, S.L. and Weiss, W.R. (1998). Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect. Immun., 66, 4193–4202.
418. Waters, A.P, Thomas, A.W., Deans, A.J., Mitchell, G.H., Hudson, D.E., Miller, L.H. et al. (1990). A merozoite receptor from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium. J. Biol. Chem., 265, 17974–17979.
419. Waters, A.P., Thomas, A.W., Mitchell, G.H. and McCutchan, T.F. (1991). Intra-generic conservation and limited inter-strain variation in a protective minor surface antigen of Plasmodium knowlesi merozoites. Mol. Biochem. Parasitol., 44, 141–144.
420. Weidanz, W.P., Melancon-Kaplan, J. and Cavacini, L.A. (1990). Cell-mediated immunity to the asexual blood stages of malarial parasites: animal models. Immunol. Lett., 25, 87–95.
421. Weinbaum, R.I., Weintraub, J., Nkrumah, F.K., Evans, C.B., Tieglaar, R.E. and Rosenberg, Y.J. (1978). Immunity to Plasmodium berghei yoelii in mice. II. Specific and nonspecific cellular and humoral responses during the course of infection. J. Immunol., 121, 629–636.
422. Weiss, W.R., Berzovsky, J.A, Houghten, R., Sedegah, M., Hollingdale, M. and Hoffman, S.L. (1992). A T cell clone directed at the circumsporozoite protein which protects mice against both P. yoelii and P. berghei. J. Immunol., 149, 2103–2109.
423. Weiss, WR., Good, M.F., Hollingdale, M.R., Miller, L.H. and Berzofsky, J.A (1989). Genetic control of immunity to Plasmodium yoelii sporozoites. J. Immunol., 143, 4263–4266.
424. Weiss, WR., Sedegah, M., Beaudoin, R.L., Miller, L.H. and Good, M.F. (1988). CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. PNAS, 85, 573–576.
425. Weiss, WR., Sedegah, M., Berzofsky, J.A. and Hoffman, S.L. (1993). The role of CD4+ T cells in immunity to malaria sporozoites. J. Immunol., 151, 2690–2698.
426. Williamson, K.C., Criscio, M.D. and Kaslow, D.C. (1993). Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230. Mol. Biochem. Parasitol., 58, 355–358.
427. Williamson, KC., Fujioka, H., Aikawa, M. and Kaslow, D.C. (1996). Stage-specific processing of Pfs230, a Plasmodium falciparum transmission blocking vaccine candidate. Mol. Biochem. Parasitol., 78, 161–169.
428. Williamson, KC., Keister, D.B., Muratova, O. and Kaslow, D.C. (1995). Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes. Mol. Biochem. Parasitol., 75, 33–42.
429. Wizel, B., Houghten, R., Church, P., Tine, J.A, Lanar, D.E., Gordon, D.M. et al. (1995a). HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodiumfalciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. J. Immunol., 155, 766–775.
430. Wizel, B., Houghten, R.A., Parker, K, Coligan, J.E., Church, P., Gordon, D.M. et al. (1995b). Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum surface sporozoite protein 2. J. Exp. Med., 182, 1435–1445.
431. Yang, C., Collins, W.E., Xiao, L., Saekhou, AM., Reed, R.C., Nelson, C.O. et al. (1997). Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite repeat region and a universal T helper epitope of tetanus toxin. Vaccine, 15, 377–386.
432. Yang, C., Shi, Y.P., Udhayakumar, V., Alpers, M.P., Povoa, M.M., Hawley, WA. et al. (1995). Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-l) of Plasmodium falciparum from field isolates. Mol. Biochem. Parasitol., 71, 291–294.
433. Yayon, A, van de Waa, J.A, Yayon, M., Geary, T.G. and Jensen, J.B. (1983). Stage dependent effects of chloroquine on Plasmodium falciparum in vitro. Protozoology, 30, 642–647.
434. Yorke, W. and Macife, J.W.S. (1924). Observations on malaria made during the tratment of general paralysis. Trans. Roy. Soc. Trop. Med. Hyg., 18, 13–44.
435. Yoshida, N., Di Santi, S.M., Dutra, AP., Nussenzweig, R.S., Nussenzweig, V. and Enea, V. (1990). Plasmodium falciparum: restricted polymorphism of T cell epitopes of the circumsporozoite protein in Brazil. Exp. Parasitol., 71, 386–392.
436. Yoshida, N., Nussenzweig, R.S., Potocnjak, P., Nussenzweig, V. and Aikawa, M. (1980). Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science, 207, 71–73.
437. Zavala, F., Masuda, A., Graves, P.M., Nussenzweig, V. and Nussenzweig, R.S. (1985). Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites. J. Immunol., 135(4), 2790–2793.
438. Zavala, F., Tam, J.P., Barr, P.J., Romero, P.J., Ley, V., Nussenzweig, R.S. et al. (1987). Synthetic peptide vaccine confers protection against murine malaria. J. Exp. Med., 166, 1591–1596.